Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM)
Roundhill Investments - GLP-1 & Weight Loss ETF operates in the Asset Management industry of the Financial Services sector, headquartered in New York, NY, US. The stock last traded at $28.76, down 1.93% on the session, giving a market capitalisation of $37.0M. Its beta of 0.47 implies it has historically moved less than the broad market.
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
Roundhill Investments - GLP-1 & Weight Loss ETF is most often compared with the following Financial Services names: